Psoriatic arthritis (PsA) is a systemic, inflammatory disease. The chronic inflammation in
PsA predisposes patients to the metabolic syndrome (MetS). MetS is associated with systemic
inflammation and proinflammatory cytokines. Clinical observations and experimental results
argue for an anti-inflammatory and immunosuppressant property of MET.
Phase:
N/A
Details
Lead Sponsor:
Faculty of Medicine, University of Alexandria University of Alexandria